{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:31:03Z","timestamp":1791379863832,"version":"4.3.3"},"reference-count":138,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2016-0852"],"award-info":[{"award-number":["2016-0852"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002426","name":"Telethon Foundation","doi-asserted-by":"publisher","award":["GGP19146"],"award-info":[{"award-number":["GGP19146"]}],"id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PRIN","award":["2017H5F943"],"award-info":[{"award-number":["2017H5F943"]}]},{"name":"ERANET","award":["ER-2017-2364981"],"award-info":[{"award-number":["ER-2017-2364981"]}]},{"name":"PRIN","award":["2017K55HLC"],"award-info":[{"award-number":["2017K55HLC"]}]},{"name":"Gilead Research scholarship grant"},{"name":"Amsterdam UMC fellowship"},{"name":"Health Holland TKI-Public Private Partnership"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Protein glycosylation is a post-translational modification consisting in the enzymatic attachment of carbohydrate chains to specific residues of the protein sequence. Several types of glycosylation have been described, with N-glycosylation and O-glycosylation being the most common types impacting on crucial biological processes, such as protein synthesis, trafficking, localization, and function. Genetic defects in genes involved in protein glycosylation may result in altered production and activity of several proteins, with a broad range of clinical manifestations, including dyslipidaemia and atherosclerosis. A large number of apolipoproteins, lipoprotein receptors, and other proteins involved in lipoprotein metabolism are glycosylated, and alterations in their glycosylation profile are associated with changes in their expression and\/or function. Rare genetic diseases and population genetics have provided additional information linking protein glycosylation to the regulation of lipoprotein metabolism.<\/jats:p>","DOI":"10.1093\/cvr\/cvaa252","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T07:10:05Z","timestamp":1598425805000},"page":"1033-1045","source":"Crossref","is-referenced-by-count":72,"title":["Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis"],"prefix":"10.1093","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2948-6257","authenticated-orcid":false,"given":"Angela","family":"Pirillo","sequence":"first","affiliation":[{"name":"Center for the Study of Atherosclerosis, E. Bassini Hospital, via M. Gorki 50, 20092 Cinisello Balsamo, Milan, Italy"},{"name":"IRCCS MultiMedica, via Milanese 300, 20099 Sesto S. Giovanni, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Svecla","sequence":"additional","affiliation":[{"name":"Department of Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti 9, Milan 20133, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberico Luigi","family":"Catapano","sequence":"additional","affiliation":[{"name":"IRCCS MultiMedica, via Milanese 300, 20099 Sesto S. Giovanni, Milan, Italy"},{"name":"Department of Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti 9, Milan 20133, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2911-2917","authenticated-orcid":false,"given":"Adriaan G","family":"Holleboom","sequence":"additional","affiliation":[{"name":"Department of Vascular Medicine, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-1257","authenticated-orcid":false,"given":"Giuseppe Danilo","family":"Norata","sequence":"additional","affiliation":[{"name":"Center for the Study of Atherosclerosis, E. Bassini Hospital, via M. Gorki 50, 20092 Cinisello Balsamo, Milan, Italy"},{"name":"Department of Pharmacological and Biomolecular Sciences, University of Milan, Via Balzaretti 9, Milan 20133, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"key":"2021032208555478200_cvaa252-B1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/glycob\/3.2.97","article-title":"Biological roles of oligosaccharides: all of the theories are correct","volume":"3","author":"Varki","year":"1993","journal-title":"Glycobiology"},{"key":"2021032208555478200_cvaa252-B2","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cell.2006.08.019","article-title":"Glycosylation in cellular mechanisms of health and disease","volume":"126","author":"Ohtsubo","year":"2006","journal-title":"Cell"},{"key":"2021032208555478200_cvaa252-B3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrm3383","article-title":"Vertebrate protein glycosylation: diversity, synthesis and function","volume":"13","author":"Moremen","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2021032208555478200_cvaa252-B4","volume-title":"Essentials of Glycobiology","author":"Stanley","year":"2017","edition":"3rd ed"},{"key":"2021032208555478200_cvaa252-B5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/10409239891204198","article-title":"Concepts and principles of O-linked glycosylation","volume":"33","author":"Van den Steen","year":"1998","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"2021032208555478200_cvaa252-B6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/MOL.0000000000000461","article-title":"New insights into the role of glycosylation in lipoprotein metabolism","volume":"28","author":"van den Boogert","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"2021032208555478200_cvaa252-B7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat Genet"},{"key":"2021032208555478200_cvaa252-B8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng.291","article-title":"Common variants at 30 loci contribute to polygenic dyslipidemia","volume":"41","author":"Kathiresan","year":"2009","journal-title":"Nat Genet"},{"key":"2021032208555478200_cvaa252-B9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"2021032208555478200_cvaa252-B10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cellimm.2018.07.009","article-title":"Immunoglobulin G glycosylation in aging and diseases","volume":"333","author":"Gudelj","year":"2018","journal-title":"Cell Immunol"},{"key":"2021032208555478200_cvaa252-B11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/ije\/21.2.253","article-title":"Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54,385 men and women during 20.5 years follow-up","volume":"21","author":"Lindberg","year":"1992","journal-title":"Int J Epidemiol"},{"key":"2021032208555478200_cvaa252-B12","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/HJH.0b013e32835606ae","article-title":"Combined effects of brachial pulse pressure and sialic acid for risk of cardiovascular events during 40 years of follow-up in 37,843 individuals","volume":"30","author":"Khalili","year":"2012","journal-title":"J Hypertens"},{"key":"2021032208555478200_cvaa252-B13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/cbf.1369","article-title":"Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease","volume":"25","author":"Serdar","year":"2007","journal-title":"Cell Biochem Funct"},{"key":"2021032208555478200_cvaa252-B14","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2143\/AC.62.4.2022281","article-title":"The relation between oxidant and antioxidant parameters and severity of acute coronary syndromes","volume":"62","author":"Serdar","year":"2007","journal-title":"Acta Cardiol"},{"key":"2021032208555478200_cvaa252-B15","first-page":"BC09","article-title":"Plasma myeloperoxidase and total sialic acid as prognostic indicators in acute coronary syndrome","volume":"10","author":"Govindarajan","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"2021032208555478200_cvaa252-B16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0021-9150(99)00074-X","article-title":"Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain","volume":"145","author":"Wu","year":"1999","journal-title":"Atherosclerosis"},{"key":"2021032208555478200_cvaa252-B17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0002-8703(98)70008-0","article-title":"Serum sialic acid concentration is not associated with the extent or severity of coronary artery disease in patients with stable angina pectoris","volume":"136","author":"Salomone","year":"1998","journal-title":"Am Heart J"},{"key":"2021032208555478200_cvaa252-B18","first-page":"1","article-title":"Glycosylation and its disorders: general overview","author":"Jaeken","year":"2016","journal-title":"Ref Modul Biomed Sci"},{"key":"2021032208555478200_cvaa252-B19","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(87)91287-6","article-title":"An apparent homozygous X-linked disorder with carbohydrate-deficient serum glycoproteins","volume":"330","author":"Jaeken","year":"1987","journal-title":"Lancet"},{"key":"2021032208555478200_cvaa252-B20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0387-7604(12)80276-2","article-title":"The carbohydrate deficient glycoprotein syndrome in three Japanese children","volume":"14","author":"Ohno","year":"1992","journal-title":"Brain Dev"},{"key":"2021032208555478200_cvaa252-B21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/BF00873975","article-title":"Olivopontocerebellar atrophy leading to recognition of carbohydrate-deficient glycoprotein syndrome type I","volume":"243","author":"Pavone","year":"1996","journal-title":"J Neurol"},{"key":"2021032208555478200_cvaa252-B22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jmg.38.1.14","article-title":"A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases","volume":"38","author":"de Lonlay","year":"2001","journal-title":"J Med Genet"},{"key":"2021032208555478200_cvaa252-B23","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s10545-005-0137-3","article-title":"Congenital disorder of glycosylation (CDG) Ig: report on a patient and review of the literature","volume":"28","author":"Di Rocco","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"2021032208555478200_cvaa252-B24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1161\/CIRCULATIONAHA.118.036484","article-title":"N-Glycosylation defects in humans lower low-density lipoprotein cholesterol through increased low-density lipoprotein receptor expression","volume":"140","author":"van den Boogert","year":"2019","journal-title":"Circulation"},{"key":"2021032208555478200_cvaa252-B25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/jmedgenet-2019-106102","article-title":"Hypolipidaemia among patients with PMM2-CDG is associated with low circulating PCSK9 levels: a case report followed by observational and experimental studies","volume":"57","author":"Chong","year":"2020","journal-title":"J Med Genet"},{"key":"2021032208555478200_cvaa252-B26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/jimd.12200","article-title":"Reduced CETP glycosylation and activity in patients with homozygous B4GALT1 mutations","volume":"43","author":"Boogert","year":"2020","journal-title":"J Inherit Metab Dis"},{"key":"2021032208555478200_cvaa252-B27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajhg.2013.10.024","article-title":"Solving glycosylation disorders: fundamental approaches reveal complicated pathways","volume":"94","author":"Freeze","year":"2014","journal-title":"Am J Hum Genet"},{"key":"2021032208555478200_cvaa252-B28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ajhg.2015.12.010","article-title":"CCDC115 deficiency causes a disorder of Golgi homeostasis with abnormal protein glycosylation","volume":"98","author":"Jansen","year":"2016","journal-title":"Am J Hum Genet"},{"key":"2021032208555478200_cvaa252-B29","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng.2007.45","article-title":"Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2","volume":"40","author":"Kornak","year":"2008","journal-title":"Nat Genet"},{"key":"2021032208555478200_cvaa252-B30","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tice.2016.06.006","article-title":"TMEM165 deficiencies in Congenital Disorders of Glycosylation type II (CDG-II): clues and evidences for roles of the protein in Golgi functions and ion homeostasis","volume":"49","author":"Dulary","year":"2017","journal-title":"Tissue Cell"},{"key":"2021032208555478200_cvaa252-B31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ajhg.2015.12.011","article-title":"TMEM199 deficiency is a disorder of Golgi homeostasis characterized by elevated aminotransferases, alkaline phosphatase, and cholesterol and abnormal glycosylation","volume":"98","author":"Jansen","year":"2016","journal-title":"Am J Hum Genet"},{"key":"2021032208555478200_cvaa252-B32","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/0006-291X(77)90982-2","article-title":"Demonstration of a new amidase acting on glycopeptides","volume":"76","author":"Takahashi","year":"1977","journal-title":"Biochem Biophys Res Commun"},{"key":"2021032208555478200_cvaa252-B33","volume-title":"GeneReviews((R))","author":"Lam","year":"1993"},{"key":"2021032208555478200_cvaa252-B34","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cmet.2011.11.005","article-title":"Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man","volume":"14","author":"Holleboom","year":"2011","journal-title":"Cell Metab"},{"key":"2021032208555478200_cvaa252-B35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cmet.2016.07.012","article-title":"Loss of function of GALNT2 lowers high-density lipoproteins in humans, nonhuman primates, and rodents","volume":"24","author":"Khetarpal","year":"2016","journal-title":"Cell Metab"},{"key":"2021032208555478200_cvaa252-B36","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/brain\/awaa063","article-title":"Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function","volume":"143","author":"Zilmer","year":"2020","journal-title":"Brain"},{"key":"2021032208555478200_cvaa252-B37","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa1508419","article-title":"Variant ASGR1 associated with a reduced risk of coronary artery disease","volume":"374","author":"Nioi","year":"2016","journal-title":"N Engl J Med"},{"key":"2021032208555478200_cvaa252-B38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.atherosclerosis.2020.07.001","article-title":"Common gene variants in ASGR1 gene locus associate with reduced cardiovascular risk in absence of pleiotropic effects","volume":"306","author":"Ali","year":"2020","journal-title":"Atherosclerosis"},{"key":"2021032208555478200_cvaa252-B39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0022-2275(20)40729-1","article-title":"Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease","volume":"34","author":"Tertov","year":"1993","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B40","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1021\/bi00652a024","article-title":"The monosaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoproteins","volume":"15","author":"Swaminathan","year":"1976","journal-title":"Biochemistry"},{"key":"2021032208555478200_cvaa252-B41","doi-asserted-by":"crossref","first-page":"17925","DOI":"10.1016\/S0021-9258(19)81305-4","article-title":"Mutagenesis of the glycosylation site of human ApoCIII. O-linked glycosylation is not required for ApoCIII secretion and lipid binding","volume":"263","author":"Roghani","year":"1988","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.trsl.2014.03.008","article-title":"Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction","volume":"164","author":"Cubedo","year":"2014","journal-title":"Transl Res"},{"key":"2021032208555478200_cvaa252-B43","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/pr4012393","article-title":"Glycomic analysis of high density lipoprotein shows a highly sialylated particle","volume":"13","author":"Huang","year":"2014","journal-title":"J Proteome Res"},{"key":"2021032208555478200_cvaa252-B44","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/0006-291X(89)91982-7","article-title":"Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients","volume":"162","author":"Orekhov","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"2021032208555478200_cvaa252-B45","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/0006-291X(90)90639-5","article-title":"Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography","volume":"167","author":"Tertov","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"2021032208555478200_cvaa252-B46","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0022-2275(20)41506-8","article-title":"Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation","volume":"33","author":"Orekhov","year":"1992","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B47","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0021-9150(95)05715-3","article-title":"Desialylated LDL uptake in human and mouse macrophages can be mediated by a lectin receptor","volume":"121","author":"Grewal","year":"1996","journal-title":"Atherosclerosis"},{"key":"2021032208555478200_cvaa252-B48","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbalip.2019.01.005","article-title":"Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties","volume":"1864","author":"Sukhorukov","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2021032208555478200_cvaa252-B49","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0021-9150(98)00057-4","article-title":"Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: in vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages","volume":"139","author":"Harada","year":"1998","journal-title":"Atherosclerosis"},{"key":"2021032208555478200_cvaa252-B50","first-page":"107","article-title":"Chemical composition of circulating native and desialylated low density lipoprotein: what is the difference?","volume":"1","author":"Alipov","year":"2017","journal-title":"Vessel Plus"},{"key":"2021032208555478200_cvaa252-B51","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1194\/jlr.M200077-JLR200","article-title":"The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL","volume":"43","author":"Vukmirica","year":"2002","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B52","doi-asserted-by":"crossref","first-page":"21435","DOI":"10.3390\/ijms141121435","article-title":"Glycosyltransferase GLT8D2 positively regulates ApoB100 protein expression in hepatocytes","volume":"14","author":"Wei","year":"2013","journal-title":"IJMS"},{"key":"2021032208555478200_cvaa252-B53","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1161\/01.ATV.17.11.2982","article-title":"Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells","volume":"17","author":"Macri","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021032208555478200_cvaa252-B54","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/glycob\/cwi033","article-title":"Site-specific glycosylation analysis of human apolipoprotein B100 using LC\/ESI MS\/MS","volume":"15","author":"Harazono","year":"2005","journal-title":"Glycobiology"},{"key":"2021032208555478200_cvaa252-B55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/exmp.1997.2216","article-title":"Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima","volume":"64","author":"Tertov","year":"1997","journal-title":"Exp Mol Pathol"},{"key":"2021032208555478200_cvaa252-B56","first-page":"665","article-title":"Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization","volume":"67","author":"Tertov","year":"1992","journal-title":"Lab Invest"},{"key":"2021032208555478200_cvaa252-B57","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0009-8981(93)90027-2","article-title":"LDL sialic acid content in patients with coronary artery disease","volume":"221","author":"Ruelland","year":"1993","journal-title":"Clin Chim Acta"},{"key":"2021032208555478200_cvaa252-B58","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ejlt.200700189","article-title":"Changes in sialylation of low-density lipoprotein in coronary artery disease","volume":"110","author":"Goodarzi","year":"2008","journal-title":"Eur J Lipid Sci Technol"},{"key":"2021032208555478200_cvaa252-B59","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2147\/VHRM.S112948","article-title":"Carbohydrate composition of circulating multiple-modified low-density lipoprotein","volume":"12","author":"Zakiev","year":"2016","journal-title":"Vhrm"},{"key":"2021032208555478200_cvaa252-B60","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0022-2275(20)32017-4","article-title":"Sialic acid content of low density lipoprotein and its relation to lipid concentrations and metabolism of low density lipoprotein and cholesterol","volume":"41","author":"Lindbohm","year":"2000","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B61","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.031139","article-title":"Functional metabolomics characterizes a key role for N-acetylneuraminic acid in coronary artery diseases","volume":"137","author":"Zhang","year":"2018","journal-title":"Circulation"},{"key":"2021032208555478200_cvaa252-B62","doi-asserted-by":"crossref","first-page":"14689","DOI":"10.1074\/jbc.RA118.004589","article-title":"Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice","volume":"293","author":"White","year":"2018","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B63","doi-asserted-by":"crossref","first-page":"17312","DOI":"10.1074\/jbc.M113.545053","article-title":"Low density lipoprotein receptor class A repeats are O-glycosylated in linker regions","volume":"289","author":"Pedersen","year":"2014","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B64","doi-asserted-by":"crossref","first-page":"8815","DOI":"10.1016\/S0021-9258(18)81866-X","article-title":"Effect of inhibiting N-glycosylation on the stability and binding activity of the low density lipoprotein receptor","volume":"264","author":"Filipovic","year":"1989","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B65","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/2211-5463.12740","article-title":"Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia","volume":"9","author":"Kizhakkedath","year":"2019","journal-title":"FEBS Open Bio"},{"key":"2021032208555478200_cvaa252-B66","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1073\/pnas.85.12.4335","article-title":"Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors","volume":"85","author":"Kozarsky","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021032208555478200_cvaa252-B67","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0092-8674(86)90841-X","article-title":"Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal\/UDP-GalNAc 4-epimerase deficient mutant","volume":"44","author":"Kingsley","year":"1986","journal-title":"Cell"},{"key":"2021032208555478200_cvaa252-B68","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1074\/jbc.M117.817981","article-title":"Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions","volume":"293","author":"Wang","year":"2018","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B69","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1194\/jlr.M027300","article-title":"Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice","volume":"53","author":"Yang","year":"2012","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B70","doi-asserted-by":"crossref","first-page":"12624","DOI":"10.1074\/jbc.M011063200","article-title":"Asialoglycoprotein receptor deficiency in mice lacking the major receptor subunit. Its obligate requirement for the stable expression of oligomeric receptor","volume":"276","author":"Tozawa","year":"2001","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B71","doi-asserted-by":"crossref","first-page":"13299","DOI":"10.1016\/S0021-9258(18)45201-5","article-title":"Low binding capacity and altered O-linked glycosylation of low density lipoprotein receptor in a monensin-resistant mutant of Chinese hamster ovary cells","volume":"262","author":"Yoshimura","year":"1987","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B72","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0021-9258(19)75799-8","article-title":"Chinese hamster ovary cell mutant with defective down-regulation of low density lipoprotein receptors","volume":"262","author":"Tomita","year":"1987","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B73","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1194\/jlr.R071233","article-title":"Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology","volume":"57","author":"Nordestgaard","year":"2016","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B74","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/330132a0","article-title":"cDNA sequence of human apolipoprotein(a) is homologous to plasminogen","volume":"330","author":"McLean","year":"1987","journal-title":"Nature"},{"key":"2021032208555478200_cvaa252-B75","doi-asserted-by":"crossref","first-page":"8712","DOI":"10.1016\/S0021-9258(19)84439-3","article-title":"Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a)","volume":"261","author":"Fless","year":"1986","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B76","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1139\/o86-133","article-title":"Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a)","volume":"64","author":"Seman","year":"1986","journal-title":"Biochem Cell Biol"},{"key":"2021032208555478200_cvaa252-B77","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0022-2275(20)32192-1","article-title":"Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro","volume":"39","author":"Bonen","year":"1998","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B78","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1515\/bchm3.1987.368.2.1533","article-title":"Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions","volume":"368","author":"Kratzin","year":"1987","journal-title":"Biol Chem Hoppe Seyler"},{"key":"2021032208555478200_cvaa252-B79","doi-asserted-by":"crossref","first-page":"22200","DOI":"10.1074\/jbc.M102150200","article-title":"Structural elucidation of the N- and O-glycans of human apolipoprotein(a): role of o-glycans in conferring protease resistance","volume":"276","author":"Garner","year":"2001","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B80","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1002\/elps.200410421","article-title":"Direct targeting of human plasma for matrix-assisted laser desorption\/ionization and analysis of plasma proteins by time of flight-mass spectrometry","volume":"26","author":"Jin","year":"2005","journal-title":"Electrophoresis"},{"key":"2021032208555478200_cvaa252-B81","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1021\/acs.jproteome.7b00604","article-title":"Targeted measurements of O- and N-glycopeptides show that proteins in high density lipoprotein particles are enriched with specific glycosylation compared to plasma","volume":"17","author":"Kailemia","year":"2018","journal-title":"J Proteome Res"},{"key":"2021032208555478200_cvaa252-B82","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2174\/0929867325666180530110543","article-title":"Biological consequences of dysfunctional HDL","volume":"26","author":"Pirillo","year":"2019","journal-title":"Curr Med Chem"},{"key":"2021032208555478200_cvaa252-B83","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1021\/acs.jproteome.5b00730","article-title":"Combined high-density lipoprotein proteomic and glycomic profiles in patients at risk for coronary artery disease","volume":"14","author":"Krishnan","year":"2015","journal-title":"J Proteome Res"},{"key":"2021032208555478200_cvaa252-B84","doi-asserted-by":"crossref","first-page":"43728","DOI":"10.1038\/srep43728","article-title":"HDL glycoprotein composition and site-specific glycosylation differentiates between clinical groups and affects IL-6 secretion in lipopolysaccharide-stimulated monocytes","volume":"7","author":"Krishnan","year":"2017","journal-title":"Sci Rep"},{"key":"2021032208555478200_cvaa252-B85","doi-asserted-by":"crossref","first-page":"e104833","DOI":"10.1371\/journal.pone.0104833","article-title":"Reduced apolipoprotein glycosylation in patients with the metabolic syndrome","volume":"9","author":"Savinova","year":"2014","journal-title":"PLoS One"},{"key":"2021032208555478200_cvaa252-B86","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/CS20110638","article-title":"O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?","volume":"123","author":"Lima","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"2021032208555478200_cvaa252-B87","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1016\/S0021-9258(18)53318-4","article-title":"O-linked glycosylation modifies the association of apolipoprotein A-II to high density lipoproteins","volume":"268","author":"Remaley","year":"1993","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B88","doi-asserted-by":"crossref","first-page":"9094","DOI":"10.1016\/S0021-9258(18)81907-X","article-title":"Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194","volume":"264","author":"Wernette-Hammond","year":"1989","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B89","doi-asserted-by":"crossref","first-page":"9137","DOI":"10.1016\/S0021-9258(18)60504-6","article-title":"Expression of ApoE gene in Chinese hamster cells with a reversible defect in O-glycosylation. Glycosylation is not required for apoE secretion","volume":"264","author":"Zanni","year":"1989","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B90","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1074\/mcp.M900430-MCP200","article-title":"Glycosylation and sialylation of macrophage-derived human apolipoprotein E analyzed by SDS-PAGE and mass spectrometry: evidence for a novel site of glycosylation on Ser290","volume":"9","author":"Lee","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"2021032208555478200_cvaa252-B91","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1021\/acs.jproteome.9b00450","article-title":"Site-specific glycoprofiles of HDL-associated ApoE are correlated with HDL functional capacity and unaffected by short-term diet","volume":"18","author":"Zhu","year":"2019","journal-title":"J Proteome Res"},{"key":"2021032208555478200_cvaa252-B92","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1074\/jbc.275.7.4759","article-title":"Transport and processing of endogenously synthesized ApoE on the macrophage cell surface","volume":"275","author":"Zhao","year":"2000","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B93","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1038\/s41467-018-05322-1","article-title":"Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation","volume":"9","author":"Bonacina","year":"2018","journal-title":"Nat Commun"},{"key":"2021032208555478200_cvaa252-B94","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/978-3-319-09665-0_15","article-title":"HDL in infectious diseases and sepsis","volume":"224","author":"Pirillo","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"2021032208555478200_cvaa252-B95","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MOL.0b013e32834adac3","article-title":"HDLs, immunity, and atherosclerosis","volume":"22","author":"Norata","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"2021032208555478200_cvaa252-B96","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0026-0495(99)90136-1","article-title":"Desialylation of human apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver esterified cholesterol to the liver","volume":"48","author":"Marmillot","year":"1999","journal-title":"Metabolism"},{"key":"2021032208555478200_cvaa252-B97","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1042\/bj2940879","article-title":"Lecithin: cholesterol acyltransferase: role of N-linked glycosylation in enzyme function","volume":"294","author":"O","year":"1993","journal-title":"Biochem J"},{"key":"2021032208555478200_cvaa252-B98","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1021\/bi00227a010","article-title":"Effects of inhibitors of N-linked oligosaccharide processing on the secretion, stability, and activity of lecithin: cholesterol acyltransferase","volume":"30","author":"Collet","year":"1991","journal-title":"Biochemistry"},{"key":"2021032208555478200_cvaa252-B99","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/pro.5560040419","article-title":"Site-specific detection and structural characterization of the glycosylation of human plasma proteins lecithin: cholesterol acyltransferase and apolipoprotein D using HPLC\/electrospray mass spectrometry and sequential glycosidase digestion","volume":"4","author":"Schindler","year":"2008","journal-title":"Protein Sci"},{"key":"2021032208555478200_cvaa252-B100","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/pro.2373","article-title":"Recombinant human lecithin-cholesterol acyltransferase Fc fusion: analysis of N- and O-linked glycans and identification and elimination of a xylose-based O-linked tetrasaccharide core in the linker region","volume":"22","author":"Spahr","year":"2013","journal-title":"Protein Sci"},{"key":"2021032208555478200_cvaa252-B101","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1021\/bi00070a021","article-title":"Human plasma cholesteryl ester transfer protein consists of a mixture of two forms reflecting variable glycosylation at asparagine 341","volume":"32","author":"Stevenson","year":"1993","journal-title":"Biochemistry"},{"key":"2021032208555478200_cvaa252-B102","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","article-title":"Plasma cholesteryl ester transfer protein","volume":"34","author":"Tall","year":"1993","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B103","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbalip.2011.06.013","article-title":"Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism","volume":"1821","author":"Albers","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"2021032208555478200_cvaa252-B104","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1194\/jlr.R082503","article-title":"Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis","volume":"59","author":"Jiang","year":"2018","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B105","doi-asserted-by":"crossref","first-page":"9388","DOI":"10.1016\/S0021-9258(17)37120-X","article-title":"Complete cDNA encoding human phospholipid transfer protein from human endothelial cells","volume":"269","author":"Day","year":"1994","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B106","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/S0022-2275(20)32500-1","article-title":"Biosynthesis and secretion of human plasma phospholipid transfer protein","volume":"39","author":"Huuskonen","year":"1998","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B107","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10930-006-0008-2","article-title":"N-Glycosylation is required for secretion-competent human plasma phospholipid transfer protein","volume":"25","author":"Qu","year":"2006","journal-title":"Protein J"},{"key":"2021032208555478200_cvaa252-B108","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.bbapap.2011.04.004","article-title":"Impact of site-specific N-glycosylation on cellular secretion, activity and specific activity of the plasma phospholipid transfer protein","volume":"1814","author":"Albers","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"2021032208555478200_cvaa252-B109","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/cvr\/cvz127","article-title":"Immunometabolic function of cholesterol in cardiovascular disease and beyond","volume":"115","author":"Yvan-Charvet","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2021032208555478200_cvaa252-B110","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tips.2018.12.006","article-title":"Lysosomal acid lipase: from cellular lipid handler to immunometabolic target","volume":"40","author":"Gomaraschi","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"2021032208555478200_cvaa252-B111","doi-asserted-by":"crossref","first-page":"16925","DOI":"10.1002\/jcp.28393","article-title":"Scavenger receptor class B type I as a potential risk stratification biomarker and therapeutic target in cardiovascular disease","volume":"234","author":"Sahebi","year":"2019","journal-title":"J Cell Physiol"},{"key":"2021032208555478200_cvaa252-B112","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1074\/jbc.M211073200","article-title":"Identification of the N-linked glycosylation sites on the high density lipoprotein (HDL) receptor SR-BI and assessment of their effects on HDL binding and selective lipid uptake","volume":"278","author":"Vinals","year":"2003","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B113","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1399-0004.2011.01682.x","article-title":"Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans","volume":"79","author":"Brunham","year":"2011","journal-title":"Clin Genet"},{"key":"2021032208555478200_cvaa252-B114","doi-asserted-by":"crossref","first-page":"e45660","DOI":"10.1371\/journal.pone.0045660","article-title":"Functional characterization of newly-discovered mutations in human SR-BI","volume":"7","author":"Chadwick","year":"2012","journal-title":"PLoS One"},{"key":"2021032208555478200_cvaa252-B115","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"2021032208555478200_cvaa252-B116","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.tips.2015.07.001","article-title":"Apolipoprotein C-III: from pathophysiology to pharmacology","volume":"36","author":"Norata","year":"2015","journal-title":"Trends Pharmacol Sci"},{"key":"2021032208555478200_cvaa252-B117","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"Crosby","year":"2014","journal-title":"N Engl J Med"},{"key":"2021032208555478200_cvaa252-B118","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"J\u00f8rgensen","year":"2014","journal-title":"N Engl J Med"},{"key":"2021032208555478200_cvaa252-B119","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/ATVBAHA.117.309007","article-title":"Apolipoprotein C-III levels and incident coronary artery disease risk: the EPIC-Norfolk Prospective Population Study","volume":"37","author":"van Capelleveen","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021032208555478200_cvaa252-B120","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0022-2275(20)37424-1","article-title":"Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions","volume":"38","author":"Fredenrich","year":"1997","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B121","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0378-4347(87)80057-9","article-title":"Characterization of an apolipoprotein C-III mutant by high-performance liquid chromatography and time-of-flight secondary ion mass spectrometry","volume":"414","author":"Jabs","year":"1987","journal-title":"J Chromatogr"},{"key":"2021032208555478200_cvaa252-B122","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0022-2275(20)38574-6","article-title":"Molecular cloning of a human apoC-III variant: Thr 74\u2014Ala 74 mutation prevents O-glycosylation","volume":"28","author":"Maeda","year":"1987","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B123","doi-asserted-by":"crossref","first-page":"e0144138","DOI":"10.1371\/journal.pone.0144138","article-title":"The association of human apolipoprotein C-III sialylation proteoforms with plasma triglycerides","volume":"10","author":"Yassine","year":"2015","journal-title":"PLoS One"},{"key":"2021032208555478200_cvaa252-B124","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1515\/cclm-2017-1099","article-title":"Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease","volume":"56","author":"Olivieri","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"2021032208555478200_cvaa252-B125","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0021-9150(80)90182-3","article-title":"The distribution of apo C-II and apo C-III in very low density lipoproteins of normal and type IV subjects","volume":"35","author":"Catapano","year":"1980","journal-title":"Atherosclerosis"},{"key":"2021032208555478200_cvaa252-B126","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/ATVBAHA.119.312723","article-title":"ApoC-III glycoforms are differentially cleared by hepatic TRL (triglyceride-rich lipoprotein) receptors","volume":"39","author":"Kegulian","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2021032208555478200_cvaa252-B127","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1194\/jlr.P064816","article-title":"Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes","volume":"57","author":"Koska","year":"2016","journal-title":"J Lipid Res"},{"key":"2021032208555478200_cvaa252-B128","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbalip.2011.10.010","article-title":"Regulation of triglyceride metabolism by angiopoietin-like proteins","volume":"1821","author":"Mattijssen","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"2021032208555478200_cvaa252-B129","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.jacc.2017.02.030","article-title":"ANGPTL3 deficiency and protection against coronary artery disease","volume":"69","author":"Stitziel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2021032208555478200_cvaa252-B130","doi-asserted-by":"crossref","first-page":"36293","DOI":"10.1074\/jbc.M110.156950","article-title":"O-glycosylation modulates proprotein convertase activation of angiopoietin-like protein 3: possible role of polypeptide GalNAc-transferase-2 in regulation of concentrations of plasma lipids","volume":"285","author":"Schjoldager","year":"2010","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.cmet.2007.07.009","article-title":"Hepatic proprotein convertases modulate HDL metabolism","volume":"6","author":"Jin","year":"2007","journal-title":"Cell Metab"},{"key":"2021032208555478200_cvaa252-B132","doi-asserted-by":"crossref","first-page":"9893","DOI":"10.1073\/pnas.1203563109","article-title":"Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells","volume":"109","author":"Schjoldager","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021032208555478200_cvaa252-B133","doi-asserted-by":"crossref","first-page":"717","DOI":"10.17219\/acem\/62325","article-title":"The role of CD36 receptor in the pathogenesis of atherosclerosis","volume":"26","author":"Choroma\u0144ska","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"2021032208555478200_cvaa252-B134","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.bbadis.2016.09.004","article-title":"Post-translational modifications of CD36 (SR-B2): implications for regulation of myocellular fatty acid uptake","volume":"1862","author":"Luiken","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"2021032208555478200_cvaa252-B135","doi-asserted-by":"crossref","first-page":"16277","DOI":"10.1074\/jbc.M109.007849","article-title":"The human scavenger receptor CD36: glycosylation status and its role in trafficking and function","volume":"284","author":"Hoosdally","year":"2009","journal-title":"J Biol Chem"},{"key":"2021032208555478200_cvaa252-B136","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1053\/j.gastro.2009.05.051","article-title":"Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36","volume":"137","author":"Hsieh","year":"2009","journal-title":"Gastroenterology"},{"key":"2021032208555478200_cvaa252-B137","doi-asserted-by":"crossref","first-page":"e18417","DOI":"10.1371\/journal.pone.0018417","article-title":"Acute regulation of cardiac metabolism by the hexosamine biosynthesis pathway and protein O-GlcNAcylation","volume":"6","author":"Laczy","year":"2011","journal-title":"PLoS One"},{"key":"2021032208555478200_cvaa252-B138","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00018-018-2978-6","article-title":"Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complex","volume":"76","author":"Kawecki","year":"2019","journal-title":"Cell Mol Life Sci"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvaa252\/34333543\/cvaa252.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/117\/4\/1033\/36650529\/cvaa252.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/117\/4\/1033\/36650529\/cvaa252.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T04:58:33Z","timestamp":1616389113000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/117\/4\/1033\/5901540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":138,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,9,4]]},"published-print":{"date-parts":[[2021,3,21]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvaa252","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,9,4]]}}}